This is the authors' abstract. We don't add key points for this paper.
Insertion of an anthranilic acid in an amyloidogenic peptide sequence generates a novel conformationally restricted α/β-hybrid peptide that inhibits amyloid formation of Aβ(1-40) and disrupts preformed fibrillar aggregates in vitro. Such β-sheet breaker hybrid peptides (BSBHps) may be useful for designing novel physiologically important compounds relevant to diverse amyloidoses and for studying the process of aggregation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Paul et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: